Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Triggering and resolution of inflammation in NASH
Susanne Schuster, Daniel Cabrera, Marco Arrese, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 6, pp. 349-364
Closed Access | Times Cited: 726

Showing 1-25 of 726 citing articles:

Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1228
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
Ze Chen, Ruifeng Tian, Zhi‐Gang She, et al.
Free Radical Biology and Medicine (2020) Vol. 152, pp. 116-141
Open Access | Times Cited: 899
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
Giovanni Targher, Christopher D. Byrne, Herbert Tilg
Gut (2020) Vol. 69, Iss. 9, pp. 1691-1705
Open Access | Times Cited: 571
Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice
Xianjun Luo, Honggui Li, Linqiang Ma, et al.
Gastroenterology (2018) Vol. 155, Iss. 6, pp. 1971-1984.e4
Open Access | Times Cited: 301
Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits
Moritz Peiseler, Robert F. Schwabe, Jochen Hampe, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1136-1160
Open Access | Times Cited: 287
Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids
Seon Ju Mun, Jae‐Sung Ryu, Mi‐Ok Lee, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 5, pp. 970-985
Closed Access | Times Cited: 258
Role of liver sinusoidal endothelial cells in liver diseases
Jordi Gracia‐Sancho, Esther Caparrós, Anabel Fernández‐Iglesias, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 6, pp. 411-431
Closed Access | Times Cited: 251
Cirrhosis-associated immune dysfunction
Agustı́n Albillos, Rosa Martín‐Mateos, Van der Merwe, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 2, pp. 112-134
Open Access | Times Cited: 247
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
Sven Francque, Gyöngyi Szabó, Manal F. Abdelmalek, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 1, pp. 24-39
Closed Access | Times Cited: 240
Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation
Jinchunzi Yang, Marta Fernández‐Galilea, Leyre Martínez‐Fernández, et al.
Nutrients (2019) Vol. 11, Iss. 4, pp. 872-872
Open Access | Times Cited: 229
The ménage à trois of autophagy, lipid droplets and liver disease
Yasmina Filali-Mouncef, Catherine J. Hunter, Federica Roccio, et al.
Autophagy (2021) Vol. 18, Iss. 1, pp. 50-72
Open Access | Times Cited: 214
Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis
Santosh Kumar, Qihua Duan, Rongxue Wu, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113869-113869
Closed Access | Times Cited: 210
Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis
Yong Rao, Zhiqi Kuang, Chan Li, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 199
Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases
Yongfeng Song, Junjun Liu, Ke Zhao, et al.
Cell Metabolism (2021) Vol. 33, Iss. 10, pp. 1911-1925
Open Access | Times Cited: 187
The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis
Jingjing Cai, Xiao‐Jing Zhang, Hongliang Li
Hepatology (2019) Vol. 70, Iss. 3, pp. 1026-1037
Closed Access | Times Cited: 173
Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease
Eleonora Scorletti, Paul R. Afolabi, Elizabeth A. Miles, et al.
Gastroenterology (2020) Vol. 158, Iss. 6, pp. 1597-1610.e7
Open Access | Times Cited: 172
Animal models of NAFLD from a hepatologist's point of view
Daniel Jahn, Stefan Kircher, Heike M. Hermanns, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1865, Iss. 5, pp. 943-953
Open Access | Times Cited: 169
Lytic cell death in metabolic liver disease
Jérémie Gautheron, Gregory J. Gores, Cecília M. P. Rodrigues
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 394-408
Open Access | Times Cited: 165
Immunological mechanisms and therapeutic targets of fatty liver diseases
Hua Wang, Wajahat Z. Mehal, Laura E. Nagy, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 73-91
Open Access | Times Cited: 152
Myeloid‐Cell–Specific IL‐6 Signaling Promotes MicroRNA‐223‐Enriched Exosome Production to Attenuate NAFLD‐Associated Fibrosis
Xin Hou, Shi Yin, Ruixue Ren, et al.
Hepatology (2020) Vol. 74, Iss. 1, pp. 116-132
Open Access | Times Cited: 147
Microbiota‐Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling
Fanta Barrow, Saad Khan, Gavin Fredrickson, et al.
Hepatology (2021) Vol. 74, Iss. 2, pp. 704-722
Open Access | Times Cited: 139
TGF-β Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer
Nancy R. Gough, Xiyan Xiang, Lopa Mishra
Gastroenterology (2021) Vol. 161, Iss. 2, pp. 434-452.e15
Open Access | Times Cited: 139
Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development
Pau Vancells Lujan, Esther Viñas Esmel, Emilio Sacanella
Nutrients (2021) Vol. 13, Iss. 5, pp. 1442-1442
Open Access | Times Cited: 138
Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development
Xiaochen Wang, Qifeng He, Chuanli Zhou, et al.
Immunity (2022) Vol. 56, Iss. 1, pp. 58-77.e11
Open Access | Times Cited: 110
Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1
Bridget S. Gosis, Shogo Wada, Chelsea Thorsheim, et al.
Science (2022) Vol. 376, Iss. 6590
Open Access | Times Cited: 95
Page 1 - Next Page

Scroll to top